Pharmacological

PreclinicalSmall molecule

UUniversity of Virginia

Pharmacological is one of 9 small molecule programs targeting Opioids. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

OpioidsCompleted

SmokersCompleted

OpioidsPreclinical

Completed

SmokersPreclinical

Completed

Competition

Competitive Landscape

6 competitors in Smokers

#DrugCompanyPhaseTrials

Epivir

GGlaxo Dba Glaxosmithkline

Phase 1

1 2

Rapamycin

MMaastricht Radiation Oncology

Phase 1

1 3

Nicotine Lozenge

FFertin Pharma A/S

Preclinical

1 4

Pharmacological

UUniversity of Virginia

Preclinical

1 5

Reduced Nicotine Content Cigarettes

MMilton S. Hershey Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Opioids1 trial

Care Management for the Effective Use of Opioids

Completed·VVA Office of Research and Development·N/A·NCT01236521·261 enrolled

Smokers1 trial

Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit

Completed·UUniversity of Virginia·N/A·NCT02905656·903 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Pharmacological. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Pharmacological compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Pharmacological. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Virginia company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Virginia

Pharmacological

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Opioids1 trial

Smokers1 trial

References

Drug Info

Quick Facts

Related News